Nuwellis Inc Cash Flow Conversion Efficiency
Nuwellis Inc cash flow conversion efficiency. Based on the latest financial reports, Nuwellis Inc (NUWE) has a cash flow conversion efficiency ratio of 1.553x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-3.17 Million) by net assets ($-2.04 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Nuwellis Inc (2003–2025)
Cash flow conversion efficiency of Nuwellis Inc from 2003 to 2025. This chart illustrates how Nuwellis Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Nuwellis Inc for real-time trading data and today's change.
Nuwellis Inc Cash Flow Conversion Ratio Explained
Nuwellis Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Nuwellis Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nuwellis Inc ranked by their cash flow conversion efficiency. Also see market cap of Nuwellis Inc for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
SIGNATURE RESOURCES NEW
F:3S30
|
1.468x |
|
Global Power Solutions Corp.
V:PWER
|
0.240x |
|
NuGen Medical Devices Inc
V:NGMD
|
0.066x |
|
Imagine Lithium Inc
V:ILI
|
-0.005x |
|
Aptevo Therapeutics Inc
NASDAQ:APVO
|
-0.903x |
|
Lanesborough Real Estate Investment Trust
V:LRT-UN
|
0.011x |
|
ROUTE1 INC.
F:3R6N
|
-0.683x |
|
Nexera Energy Inc
V:NGY
|
-0.007x |
Annual Cash Flow Conversion Efficiency for Nuwellis Inc (2003–2025)
The table below shows the annual cash flow conversion efficiency of Nuwellis Inc from 2003 to 2025. Review Nuwellis Inc (NUWE) financial flexibility to assess the company's free cash flow relative to its total liabilities.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.63 Million | $-10.81 Million | -4.110x | -179.85% |
| 2024-12-31 | $6.53 Million | $-9.59 Million | -1.469x | +73.71% |
| 2023-12-31 | $3.21 Million | $-17.94 Million | -5.586x | -355.66% |
| 2022-12-31 | $12.36 Million | $-15.15 Million | -1.226x | -78.27% |
| 2021-12-31 | $25.95 Million | $-17.84 Million | -0.688x | +32.29% |
| 2020-12-31 | $16.32 Million | $-16.57 Million | -1.016x | +87.65% |
| 2019-12-31 | $1.99 Million | $-16.37 Million | -8.225x | -235.31% |
| 2018-12-31 | $5.94 Million | $-14.56 Million | -2.453x | -234.14% |
| 2017-12-31 | $16.24 Million | $-11.92 Million | -0.734x | +92.08% |
| 2016-12-31 | $1.76 Million | $-16.29 Million | -9.273x | -390.92% |
| 2015-12-31 | $12.17 Million | $-22.99 Million | -1.889x | -143.69% |
| 2014-12-31 | $29.21 Million | $-22.64 Million | -0.775x | -130.92% |
| 2013-12-31 | $51.73 Million | $-17.36 Million | -0.336x | +66.78% |
| 2012-12-31 | $12.95 Million | $-13.08 Million | -1.010x | +64.52% |
| 2011-12-31 | $4.60 Million | $-13.09 Million | -2.848x | -85.26% |
| 2010-12-31 | $4.02 Million | $-6.18 Million | -1.537x | 0.00% |
| 2009-12-31 | $4.02 Million | $-6.18 Million | -1.537x | +59.74% |
| 2008-12-31 | $1.64 Million | $-6.25 Million | -3.819x | -314.53% |
| 2007-12-31 | $9.51 Million | $-8.76 Million | -0.921x | +25.15% |
| 2006-12-31 | $6.89 Million | $-8.48 Million | -1.231x | -14.82% |
| 2005-12-31 | $4.38 Million | $-4.70 Million | -1.072x | -61.61% |
| 2004-12-31 | $7.30 Million | $-4.84 Million | -0.663x | +92.54% |
| 2003-12-31 | $139.47K | $-1.24 Million | -8.886x | -- |
About Nuwellis Inc
Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly… Read more